Product Overview: Rimobolan Bayer
Rimobolan Bayer is a pharmaceutical preparation containing methenolone enanthate, a synthetic anabolic steroid derived from dihydrotestosterone. This compound represents an established research tool for investigating androgenic and anabolic signalling pathways in controlled laboratory environments. Manufactured by Bayer, this preparation maintains pharmaceutical standards for consistent research outcomes. When examining the relationship between synthetic androgens and cellular receptor interactions, researchers at Stroid UK Shop rely on authentic pharmaceutical preparations for reliable data generation.
Laboratory Applications
Research scientists utilise Rimobolan to study androgen receptor binding kinetics and downstream gene expression patterns in muscle and bone tissue models. The compound’s unique chemical structure, featuring both anabolic and reduced androgenic properties, makes it valuable for comparative steroid research protocols. Investigations into protein synthesis pathways, nitrogen retention mechanisms, and cellular proliferation responses benefit from this well-characterised compound. Researchers studying methenolone enanthate preparations often compare results against other research compounds including selective androgen receptor modulators and synthetic peptides to understand tissue-specific androgenic activity.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Methenolone Enanthate |
| Manufacturer | Bayer Pharmaceuticals |
| Chemical Class | Anabolic Steroid (DHT derivative) |
| Molecular Formula | C₂₇H₄₂O₃ |
| Molecular Weight | 414.62 g/mol |
| CAS Registry | 303-42-4 |
| Storage Requirements | Room temperature, protected from light |
| Purity Grade | Pharmaceutical standard |
Research Compliance
This pharmaceutical preparation is supplied exclusively for in-vitro research applications and laboratory analysis. Rimobolan Bayer is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper handling protocols and institutional compliance with applicable regulations governing anabolic steroid research compounds.
